Back to Search
JAMES DENHAM, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1902088644IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
MD0000039760(TN)
CMS Specialties
PrimaryPATHOLOGY
Education
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Class of 2002
Research & Publications (20)
Comprehensive Australasian multicentre dosimetric intercomparison: issues, logistics and recommendations.
PMID 19453538·J Med Imaging Radiat Oncol·2009
4-observational
Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial.
PMID 18952309·Radiother Oncol·2009
4-observational
Thrombin generation as a predictor of radiotherapy induced skin erythema.
PMID 19012979·Radiother Oncol·2009
8-other
Measuring time to biochemical failure in the TROG 96.01 trial: when should the clock start ticking?
PMID 19577859·Int J Radiat Oncol Biol Phys·2009
4-observational
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer.
PMID 19176272·Int J Radiat Oncol Biol Phys·2009
4-observational
Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study.
PMID 19017549·Radiother Oncol·2009
3-trial
PSA response signatures - a powerful new prognostic indicator after radiation for prostate cancer?
PMID 18992951·Radiother Oncol·2009
2-rct
Linear-accelerator X-ray output: a multicentre chamber-based intercomparison study in Australia and New Zealand.
PMID 19239053·Australas Phys Eng Sci Med·2008
4-observational
Comparison of prostate set-up accuracy and margins with off-line bony anatomy corrections and online implanted fiducial-based corrections.
PMID 19032399·J Med Imaging Radiat Oncol·2008
4-observational
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial.
PMID 18929505·Lancet Oncol·2008
8-other
Assessment of a daily online implanted fiducial marker-guided prostate radiotherapy process.
PMID 19032400·J Med Imaging Radiat Oncol·2008
8-other
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.
PMID 17557956·J Clin Oncol·2007
8-other
Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells.
PMID 17996308·J Neuroimmunol·2007
7-preclinical
Radiation damage to the gastrointestinal tract: mechanisms, diagnosis, and management.
PMID 18660720·Curr Opin Support Palliat Care·2007
6-review
Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.
PMID 17397033·Cancer·2007
4-observational
Telling their stories, telling our stories: physicians' experiences with patients who decide to forgo or stop treatment for cancer.
PMID 17416697·Qual Health Res·2007
4-observational
Do women have a role in early detection of prostate cancer? - Lessons from a qualitative study.
PMID 17492077·Aust Fam Physician·2007
8-other
Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors.
PMID 17253955·Stem Cells Dev·2006
8-other
Miniature LiF:Mg,Cu,P TLDs to study the effect of applicator material in 192-Ir brachytherapy.
PMID 17260583·Australas Phys Eng Sci Med·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2204 PAVILION DR, SUITE 105
KINGSPORT, TN 37660 - Phone
- (423) 392-6343
Quick Facts
- NPI
- 1902088644
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile